Novartis data at ASCO and EHA demonstrate novel approaches to reimagining medicine in cancer and serious blood disorders

Novartis Media Relations

Central media line: +41 61 324 2200

E-mail: [email protected] 

Eric Althoff

Julie Masow

Novartis US External Communications

Novartis Oncology Media Relations

+1 646 438 4335 (direct)

+1 862 778 7220 (direct)

[email protected]

[email protected]

Novartis Investor Relations

Central investor relations line: +41 61 324 7944

E-mail: [email protected]

Central

North America

Samir Shah

+41 61 324 7944

Richard Pulik

+1 212 830 2448

Pierre-Michel Bringer

+41 61 324 1065

Cory Twining

+1 212 830 2417

Thomas Hungerbuehler

+41 61 324 8425

Isabella Zinck

+41 61 324 7188